Skip to main content
Caplight Logo









Optellum

Optellum

Private
OxfordHealthcare & Life Scienceshttps://optellum.com

Last Round

Series B

Jan 8, 2026

Total Funding Raised

$18.58M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Optellum operates in Healthcare & Life Sciences and is based in Oxford. Its latest recorded funding round was a Series B round in January 2026.

Optellum is a medical technology company that develops AI-powered clinical decision-support software for the early diagnosis and management of lung cancer and other lung diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Healthcare Analytics, Precision Medicine

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Optellum Comparables

Compare Optellum with similar companies based on industry and business-model similarity.

Optellum comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RevealDx
91%
Riverain Technologies
85%
VoxelCloud
84%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Optellum Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJan 8, 2026
Series BJan 8, 2024
Series ASep 27, 2022
SeedJul 15, 2019
GrantDec 1, 2016
Grant
Oct 1, 2016
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Vaclav Potesil

Chief Product & Strategy Officer, Founder

Founding Team

Quentin Chometon

Chief Technology Officer

Executive Team

Thomas Pearson-Jones

Chief Operating Officer

Executive Team

For institutional investors. Book with your work email.

Optellum Investors

Notable investors and investment history

Optellum investors
InvestorRounds
EIT HealthGrant
IQ CapitalSeries A, Seed
Intuitive VenturesSeries B, Series A
Healthliant VenturesSeries B
Woori Venture Partners Co., Ltd.Series B
Innovate UKGrant
St. John's College, OxfordSeed
Book a demo to see all 13 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 8, 2026

    Raised Series B with investors including Healthliant Ventures and Mercia Ventures.

  • Aug 26, 2025

    Launched the world's first thorax CT foundation model for lung care.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • integrates_withOct 21, 2026

    On Oct 20th '26, Optellum integrates its Virtual Nodule Clinic with Lung Cancer Prediction AI into RapidAI's Rapid Enterprise Platform to support lung nodule identification, risk assessment, and follow-up in clinical workflows in the United Kingdom and the United States.

  • launchesAug 13, 2026

    Optellum Ltd launched Virtual Nodule Clinic with Lung Cancer Prediction AI on Jun 4th '26.

Book a demo to see all news

For institutional investors. Book with your work email.

Optellum Filings

Explore SEC and related filing metadata, where available.

Optellum filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Optellum's valuation, stock price, and market status.

Is Optellum a public or private company?

Optellum is a private company.

What is the current stock price of Optellum?

Optellum is a private company, so its shares have no public market price. Caplight tracks Optellum's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Optellum worth (valuation)?

Valuation information for Optellum is not publicly available.

Can I buy Optellum stock?

Optellum shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Optellum's last funding round?

Optellum's most recent funding round was Series B on January 8, 2026.

Who are the main investors in Optellum?

Key investors in Optellum include IQ Capital, Mercia Asset Management.

Will Optellum IPO soon?

No public IPO plans have been announced for Optellum.

How can I track Optellum secondary market activity?

Caplight tracks bids, offers, and trades in Optellum's shares on secondary markets.

Firmographic Details

HeadquartersOxford
Employee Range50
Year Founded2015
Last FundingJan 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?